In this part of the clinical approach to asthma we will discuss the background to asthma. That includes:
- Background
- Asthma vs COPD
- Reversibility in asthma
- Difficulty to manage when asthma is chronic
- Varying airflow obstruction
- Need to prevent remodeling of the lung tissue while managing asthma.
- Higher prevalence of asthma in affluent countries.
- Peak age for asthma (3 years of age)
- Gender in childhood is predominantly boys, however, the gender difference goes away in adults.
- Asthma by itself is not a fatal disease, however, asthma related deaths can occur due to the underlying inflammation and tissue damage.
- The basic principle of the management is to control the inflammation - not just the symptoms.
- Why did the mere use of beta agonists actually increased deaths in the asthma patients? (happened in 1960)
Risk Factors
- Atopy (Antigen vs. allergen)
- Infections
- Diet
- Air Pollution
- Occupational exposure
Triggers
- Why does laughing and coughing trigger asthma?
- Role of the mast cells in triggering asthma.
- Nerve irritation leading to the asthma.
- Beta blockers (can be fatal.)
- Exercise. Why does exercise trigger asthma?
- Cold air, hyperventilation
- Food
- Air pollution
- Occupational factors
- Hormones (some women before periods can have attacks of asthma.)
- Gastroeosphageal reflux
- Stress. Why will stress cause asthma?
Pathophysiology of asthma
- Airway inflammation
- Airway hyper-responsiveness
- Epithelial shedding due to irritation and inflammation.
- Loss of epithelium derived nitric oxide.
- Protection mechanism disappears leading to nerve exposure and nerve irritation.
- Thickening of the basement membrane leading to irreversibility/difficulty in management.
Airway smooth muscle changes
- Beta receptor decoupling
- Hyperplasia and hypertrophy of the airway smooth muscles
Vascular changes
- Increased blood vessels.
- More blood flow.
- Edema
- Inflammation
- Swelling
- Increased mucus secretion
Mucus hypersecretion
- Result of chronic irritation and inflammation
Diagnosis
- Pulmonary function tests and the changes
- Inhaled SABA based testing to confirm asthma.
- Blood IgE tests
- Imaging
- Skin tests
- Exhaled nitric oxide (NO)
Learning objectives of this video are the following:
1. Understanding background knowledge of asthma.
2. Pathophysiology of asthma.
3. Management of asthma.
Presented by Dr. Mobeen Syed
Faculty
In addition to the presenter, following authors may have helped with the content writing, review,
or approval:
CME, CE, CEU and Other Credit Types:
ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1
Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Disclosure Information
In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for
Continuing Medical Education), we are committed to upholding principles of balance, independence,
objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing
Education (CE) activities. These policies include the careful management and mitigation of any relevant
financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial
relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined
that these relationships are not deemed inappropriate in the context of their respective presentations.
Additionally, they are found to be consistent with the educational objectives and the integrity of the
activity.
Faculty |
Disclosures |
Dr. Mobeen Syed |
Author declares no conflict of interest. |
Write A New Comment
2 Comments
khatke.kunal@*.com
Mar 24 2019, 6:33 am
Won't the introduction of (anti-inflammatory) worsen the symptoms of asthma? if we are talking about NSAIDs.
Inhibition of COX pathway would shunt the pathway towards the other side and there would be more exaggeration of asthma as a result of the pro-inflammatory substances release.
or do we introduce steroids to decrease chronic inflammation?
elisa.fukuda@*.com
Feb 14 2019, 2:39 am
What is cme ?